Clinical Trial Update: Multiple Ascending Dose Study in Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 multiple ascending dose trial in subjects with Type 2 diabetes mellitus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Amgen | Conditions: Diabetes Mellitus | Phase 1 | Status: TERMINATED